How often is the Twinrix (hepatitis A and B vaccine) needed when traveling?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Twinrix Vaccination Schedule for Travelers

For travelers needing protection against both hepatitis A and B, complete the full Twinrix series using either the standard 3-dose schedule (0,1, and 6 months) or the accelerated 4-dose schedule (days 0,7,21-30, plus a booster at 12 months) depending on departure timing—this is not a vaccine you get repeatedly for each trip, but rather a one-time series that provides long-term protection. 1, 2

Initial Vaccination Series

Standard Schedule (Preferred When Time Permits)

  • Three doses administered at 0,1, and 6 months provide optimal long-term protection 1, 2, 3
  • At month 2 (after 2 doses), more than 99% of vaccinees achieve protection against hepatitis A and 84% against hepatitis B 3
  • After completing all 3 doses, nearly all vaccinees have protective antibody levels against both viruses, with geometric mean titers of approximately 4818 mIU/ml for hepatitis B 3

Accelerated Schedule (For Last-Minute Travelers)

  • Four doses on days 0,7, and 21-30, followed by a booster at 12 months when rapid protection is needed 1, 2, 4
  • This accelerated regimen induces early protection and is specifically designed for travelers departing within weeks of planning their trip 5, 4
  • The 12-month booster dose is essential for long-term immunity even with the accelerated schedule 1, 6

Long-Term Protection and Revaccination

Duration of Immunity

  • Long-term follow-up data through 48 months shows all vaccinees remain positive for anti-HAV antibodies and >95% maintain protection against hepatitis B 3
  • Vaccine-induced immunity persists for more than 30 years, meaning you do not need to repeat the series for subsequent trips 2
  • Once the primary series is completed, no routine booster doses are needed for future travel 3

Special Considerations for Travelers

Who Should Receive Twinrix

  • Travelers to countries with high or intermediate endemicity for both hepatitis A and B (Asia, Africa, Latin America, Middle East) 1, 5, 7
  • The combined vaccine is specifically recommended when protection against both viruses is indicated, rather than using single-antigen vaccines separately 2

Timing Before Departure

  • Start the first dose as soon as travel is considered, regardless of departure date 1
  • For travelers departing in less than 2 weeks, older adults, immunocompromised persons, and those with chronic liver disease may need additional immune globulin (IG) alongside the first vaccine dose for optimal hepatitis A protection 1
  • Note that limited data exist specifically for Twinrix in last-minute travel scenarios compared to single-antigen vaccines 1

Common Pitfalls to Avoid

  • Do not restart the series if interrupted—simply continue where you left off, as restarting wastes doses and delays protection 2
  • Do not assume you need revaccination before each trip—the primary series provides decades of protection 2, 3
  • Do not give the third dose before 16 weeks from the first dose in the standard schedule, even if 8 weeks have passed since the second dose 2
  • Do not skip the 12-month booster when using the accelerated schedule, as it is critical for long-term immunity 1, 6
  • Do not use Twinrix if you only need hepatitis B protection—reserve it for patients requiring both vaccines 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hepatitis B Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Twinrix vaccination schedules among injecting drug users.

Expert opinion on biological therapy, 2007

Research

Vaccination of travelers against hepatitis A and B.

Journal of travel medicine, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.